Skip to Content

Updated Standards for Phase I Environmental Assessment

On February 27, 2023 by Schnader in Publications

Megan Harmon published an alert, titled, “Updated Standards for Phase I Environmental Assessment.” On December 15, 2022, the United States Environmental Protection Agency (“EPA”) finally recognized ASTM Standard E1527-21 as satisfying the All Appropriate Inquiry (“AAI”) Rule (40 CFR Part 312), the standard which is used to evaluate the environmental […]

Category: Publications
Read More

Attention New York Employers: It’s Time to Update Your Employee Handbooks Again

On February 17, 2023 by Schnader in Publications

Lisa M. Brauner and Erica Briggs published an alert, “Attention New York Employers: It’s Time to Update Your Employee Handbooks Again.” On January 12, 2023, the New York State Department of Labor (“NYSDOL”) published an updated Proposed Model Sexual Harassment Prevention Policy (“Proposed Model Policy”), and provided a 30-day period, until February 11, […]

Category: Publications
Read More

Good Intentions Do Not Suffice: The Third Circuit Insists That a Mass Tort Debtor Seeking Chapter 11 Protection Be in Immediate Financial Distress

On February 14, 2023 by Schnader in Publications

Schnader published an alert, “Good Intentions Do Not Suffice: The Third Circuit Insists That a Mass Tort Debtor Seeking Chapter 11 Protection Be in Immediate Financial Distress.” Decision: In re LTL Management, LLC, Nos. 22-2003 to 22-2011 (3rd Cir. Jan. 30, 2023) This is an important opinion for litigants in […]

Category: Publications
Read More

Third Circuit Holds That Drug Manufacturers Are Not Required to Deliver Discounted Drugs to More Than One Contract Pharmacy Under the 340B Program

On February 3, 2023 by Schnader in Publications

Stephen J. Shapiro published a client alert, “Third Circuit Holds That Drug Manufacturers Are Not Required to Deliver Discounted Drugs to More Than One Contract Pharmacy Under the 340B Program.”  On January 20, 2023, the Third Circuit held that drug companies may refuse to deliver discount drugs under the 340B program […]

Category: Publications
Read More